Barbeck Mike, Motta Antonella, Migliaresi Claudio, Sader Robert, Kirkpatrick Charles James, Ghanaati Shahram
Clinic of Oro-Maxillofacial and Plastic Surgery, FORM-Lab, University Medical Center of the Goethe University, Frankfurt, Germany.
Institute of Pathology, REPAIR-Lab, University Medical Center of the Johannes Gutenberg University, Mainz, Germany.
J Biomed Mater Res A. 2016 Feb;104(2):413-8. doi: 10.1002/jbm.a.35579. Epub 2015 Oct 15.
Biomaterial-associated multinucleated giant cells (BMGCs) have been found within the implantation beds of many different biomaterials. However, their exact differentiation and their involvement in the inflammatory and healing events of the foreign body response still remain mostly unclear. Silk fibroin (SF) scaffolds, which induces a tissue reaction involving both macrophages and BMGCs, was implanted in the subcutaneous connective tissue of four CD-1 mice for 15 days using an established subcutaneous implantation model. Analysis of macrophage polarization and BMGCs was performed by immunohistochemcial detection of pro- (cyclooxygenase-2 (COX-2), C-C chemokine receptor type 7 (CCR7), nuclear factor "kappa-light-chain-enhancer" (NF-κB)) and anti-(heme oxygenase-1 (HO-1) and mannose receptor (MR, also known as CD206)). Furthermore, histochemical detection of tartrate-resistant acid phosphatase (TRAP) was conducted to test its predictive efficiency for the pro-inflammatory differentiation of cells. An established system for histomorphometrical analysis was used for counting of BMGCs expressing these molecules. The results show that BMGCs express both pro- and anti-inflammatory molecules within the implantation beds of SF scaffolds in comparable numbers, while only statistically significantly lower numbers of TRAP-positive BMGCs were measured in comparison to the BMGCs expressing the above-mentioned molecules. As these data substantiate the heterogeneity of BMGCs, the question arises to what extent BMGCs can "support" the process of tissue regeneration. Furthermore, the data prompt the question to what extent TRAP-expression within a biomaterial implantation bed can be seen as a predictive marker for an inflammatory condition, as in this study no obvious correlation between TRAP-expression and other pro-inflammatory markers could be observed.
在许多不同生物材料的植入床中都发现了生物材料相关的多核巨细胞(BMGCs)。然而,它们的确切分化过程以及它们在异物反应的炎症和愈合事件中的作用仍大多不清楚。使用已建立的皮下植入模型,将诱导涉及巨噬细胞和BMGCs的组织反应的丝素蛋白(SF)支架植入4只CD-1小鼠的皮下结缔组织中15天。通过免疫组织化学检测促炎分子(环氧化酶-2(COX-2)、C-C趋化因子受体7型(CCR7)、核因子“κ轻链增强子”(NF-κB))和抗炎分子(血红素加氧酶-1(HO-1)和甘露糖受体(MR,也称为CD206))来分析巨噬细胞极化和BMGCs。此外,进行抗酒石酸酸性磷酸酶(TRAP)的组织化学检测以测试其对细胞促炎分化的预测效率。使用已建立的组织形态计量分析系统对表达这些分子的BMGCs进行计数。结果表明,在SF支架的植入床中,BMGCs表达促炎和抗炎分子的数量相当,而与表达上述分子的BMGCs相比,仅测量到TRAP阳性BMGCs的数量在统计学上显著较低。由于这些数据证实了BMGCs的异质性,因此出现了BMGCs在多大程度上可以“支持”组织再生过程的问题。此外,这些数据引发了一个问题,即生物材料植入床内的TRAP表达在多大程度上可以被视为炎症状态的预测标志物,因为在本研究中未观察到TRAP表达与其他促炎标志物之间存在明显相关性。